Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE et al (2020) European Society of Cardiology: cardiovascular disease statistics 2019. Eur Heart J 41:12–85
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM et al (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 136:e137–e161
Gupta R, Testani J, Collins S. (2019) Diuretic resistance in heart failure. Curr Heart Fail Rep 16:57–66
Mullens W, Damman K, Harjola VP, Mebazaa A, Rocca HB, Martens P et al (2019) The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137–155
Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW et al (2021) Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 143:e254–e743
Seferovic P, Vardas P, Jankowska EA, Maggioni AP, Timmis A, Milinković I et al (2021) The Heart Failure Association Atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail [E-pub ahead of print]. https://doi.org/10.1002/ejhf.2143
Constanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure (UNLOAD trial). J Am Coll Cardiol 49:675–683
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome (CARRESS-HF trial). N Engl J Med 367:2296–2304
Lu R, Mucino-Bermejo MJ, Ribeiro LC, Tonini E, Estremadoyro C, Samoni S et al (2015) Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review. Cardiorenal Med 5:145–156
Chionh CY, Clementi A, Poh CB, Finkelstein FO, Cruz DN (2020) The use of peritoneal dialysis in heart failure: a systematic review. Perit Dial Intern 40:527–539
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 339:b2700
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ 355:i4919
McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12:55–61
Schünemann HJOA, Higgins JPT, Vist GE, Glasziou P, Akl E, Guyatt GH (2017) on behalf of the Cochrane GRADEing methods group and the Cochrane statistical methods group. Chapter 11: completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: J.P.T.C.R. Higgins, J. Chandler, M.S. Cumpston, editors. Cochrane Handbook for Systematic Reviews of Interventions version 520 (updated June 2017), Cochrane; 2017. Available from: www.training.cochrane.org/handbook
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range, and/or interquartile range. BMC Med Res Methodol 14:135
Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range and/or mid-quartil range. Stat Methods Med Res 27:1785–1805
Weir CJ, Butcher I, Assi V, Lewis SC, Murray GD, Langhorne P, Brady MC (2018) Dealing with missing standard deviation and mean values in meta-analysis of continuum outcomes: a systematic review. BMC Med Res Methodol 18:25
Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Statist Med 21:1539–1558
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Grossekettler L, Schmack B, Meyer K, Brockmann C, Wanninger R, Kreusser MM et al (2019) Peritoneal dialysis as therapeutic option in heart failure patients. ESC Heart Failure 6:271–279
Wojtaszek E, Grzejszczak A, Niemczyk S, Malyszko J, Matuszkiewicz-Rowińska J (2019) Peritoneal ultrafiltration in the long-term treatment of chronic heart failure refractory to pharmacological therapy. Front Physiol 10:310
Shao Q, Xia Y, Zhao M, Liu J, Zhang Q, Jin B et al (2018) Effectiveness and safety of peritoneal dialysis treatment in patients with refractory congestive heart failure due to chronic cardiorenal syndrome. Biomed Res Int. https://doi.org/10.1155/2018/6529283
Pavo N, Yarragudi R, Puttinger H, Arfsten H, Strunk G, Bojic A et al (2018) Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction. PLoS ONE 13:e0206830. https://doi.org/10.1371/journal.pone.0206830
Hedau S, Chakravarthi R, Reddy V (2018) Ultrafiltration by peritoneal route in refractory chronic congestive cardiac failure. Indian J Nephrol 28:298–302
Querido S, Branco P, Sousa H, Adragão T, Aguiar C, Pereira S et al (2016) Peritoneal dialysis as a successful treatment in patients with refractory congestive heart failure: a one-center experience. Clin Nephrol 85:260–265
Fröhlich H, Katus HA, Täger T, Lossnitzer N, Grossekettler L (2015) Peritoneal ultrafiltration in end-stage chronic heart failure. Clin Kidney J 8:219–225
Bertoli SV, Musetti C, Ciurlino D, Basile C, Galli E, Gambaro G (2014) Peritoneal ultrafiltration in refractory heart failure: a cohort study. Perit Dial Inter 34:64–70
Courivaud C, Kazory A, Crépin T, Azar R, Bresson-Vautrin C (2014) Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Intern 34:100–108
Rizkallah J, Sood MM, Reslerova M, Cordova F, Malik A, Sathianathan A (2013) Reduced hospitalizations in severe, refractory congestive heart failure with peritoneal dialysis: a consecutive case series. Clin Nephrol 80:334–341
Kunin M, Arad M, Dinour D, Freimark D, Holtzman EJ (2013) Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors. Blood Purif 35:285–294
Nunez J, Gonzalez M, Minana G, Garcia-Ramon R, Sanchis J, Bodı V (2012) Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail 14:540–548
Ruhi C, Kocak H, Yavuz A, Suleymanlar G, Ersoy FF (2012) Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients. Int Urol Nephrol 44:963–969
Koch M, Haastert B, Kohnle M, Rump LC (2012) Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 14:530–539
Sotirakopoulos NG, Kalogiannidou IM, Tersi ME, Mavromatidis KS (2011) Peritoneal dialysis for patients suffering from severe heart failure. Clin Nephrol 76:124–129
Sanchez JE, Ortega T, Rodriguez C, Diaz-Molina B, Martin M (2010) Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25:605–610
Cnossen TT, Kooman JP, Konings CJAM, Uszko-Lencer NHMK (2010) Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif 30:146–152
Nakayama M, Nakano H, Nakayama M (2010) Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiology 55:49–54
Díez-Ojea B, Rodríguez-Suárez C, Vidau P, Gago E, Díaz-Molina B (2007) Papel de la diálisis peritoneal en el tratamento de la insuficiencia cardíaca. Experiencia en nuestro centro Nefrologia 7:605–611
Gotloib L, Fudin R, Yakubovich M, Vienken J (2005) Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 20 [Suppl 7]: vii32–6
Stoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community populations with heart failure. Am Heart J 154:260–266
Lin A, Chin JC, Scignano NM, Evans AM (2017) Repeat hospitalization predicts mortality in patients with heart failure. Mil Med 182:e1932–e1937
Chang P, Wruck LM, Shahar E, Rossi JS, Loehr LR, Russell SD et al (2018) Trends in hospitalization and survival of acute decompensated heart failure in 4 US communities (2005–2014). ARIC Study Community Surveillance Circulation 138:12–24
Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y et al (2020) Peritoneal dialysis-related infection rates and outcomes: results from the peritonal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis 76:42–53
Fiel D, Santos J, Vicente R (2020) Predictors of peritonitis in peritoneal dialysis: experience during three decades. Port J Nephrol Hypert 34:14–20
El-Reshaid W, Al-Disawy H, Nassef H, Alhelaly U (2016) Comparison of peritonitis rates and patient survival in automated and continuous ambulatory peritoneal dialysis: a 10-year single center experience. Ren Fail 38:1187–1192
Grossekettler L, Schmack B, Brockmann C, Wanninger R, Kreusser MM, Frankenstein L et al (2020) Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients. BMC Nephrol 21:179
Dukka H, Kalra PA, Wilkie M, Bhandari S, Davies SJ, Barratt J et al (2019) Peritoneal ultrafiltration for heart failure: lessons from a randomized controlled trial. Perit Dial Int 39:468–469
留言 (0)